A woman with fever, headache, and confusionHIRSCH, Martin S; WERNER, Barbara.The New England journal of medicine. 2003, Vol 348, Num 22, pp 2239-2247, issn 0028-4793, 9 p.Article

Initiating Therapy : When to Start, What to UseHIRSCH, Martin S.The Journal of infectious diseases. 2008, Vol 197, issn 0022-1899, S252-S260, SUP3Article

Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1 -positive subjects : Results from ACTG 384GANDHI, Rajesh T; SPRITZLER, John; CHAN, Ellen et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 42, Num 4, pp 426-434, issn 1525-4135, 9 p.Article

Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity : AIDS clinical trials groups 209 and 214SCHOOLEY, Robert T; SPINO, Cathie; MCELRATH, M. Juliana et al.The Journal of infectious diseases. 2000, Vol 182, Num 5, pp 1357-1364, issn 0022-1899Article

Multilocus genetic interactions and response to efavirenz containing regimens : an Adult AIDS Clinical Trials Group studyMOTSINGER, Alison A; RITCHIE, Marylyn D; POLLARD, Richard B et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 11, pp 837-845, issn 1744-6872, 9 p.Article

Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapyWEINBERG, Adriana; TIERNEY, Camlin; KENDALL, Michelle A et al.The Journal of infectious diseases. 2006, Vol 193, Num 4, pp 488-493, issn 0022-1899, 6 p.Article

Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitorsSMITH, Patrick F; ROBBINS, Gregory K; MORSE, Gene D et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 8, pp 3558-3561, issn 0066-4804, 4 p.Article

A Woman with Fever and ConfusionHIRSCH, Martin S; DEMARIA, Alfred; SCHAEFER, Pamela W et al.The New England journal of medicine. 2008, Vol 359, Num 3, pp 294-303, issn 0028-4793, 10 p.Article

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection : 2008 Recommendations of an International AIDS Society-USA PanelHIRSCH, Martin S; GÜNTHARD, Huldrych F; YENI, Patrick G et al.Clinical infectious diseases. 2008, Vol 47, Num 2, pp 266-285, issn 1058-4838, 20 p.Article

Favorable interactions between enfuvirtide and 1-β-D-2,6-diaminopurine dioxolane in vitroTREMBLAY, Cécile L; POULIN, Danielle L; HICKS, Jennifer L et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 11, pp 3644-3646, issn 0066-4804, 3 p.Article

Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapySETH, Aruna; MARKEE, Janan; LETVIN, Norman L et al.The Journal of infectious diseases. 2001, Vol 183, Num 5, pp 722-729, issn 0022-1899Article

Antiretroviral Treatment of Adult HIV Infection : 2008 Recommendations of the International AIDS Society-USA PanelHAMMER, Scott M; ERON, Joseph J; JACOBSEN, Donna M et al.JAMA, the journal of the American Medical Association. 2008, Vol 300, Num 5, pp 555-570, issn 0098-7484, 16 p.Article

A phase ii, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitisBORUCKI, Michael J; SPRITZLER, John; NEVIN, Thomas T et al.Antiviral research. 2004, Vol 64, Num 2, pp 103-111, issn 0166-3542, 9 p.Article

Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infectionHIRSCH, Martin S; STEIGBIGEL, Roy T; LEAVITT, Randi Y et al.Clinical infectious diseases. 2003, Vol 37, Num 8, pp 1119-1124, issn 1058-4838, 6 p.Article

In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenzKOLLMANN, Christopher; TREMBLAY, Cecile; GIGUEL, Francoise et al.Antiviral therapy (London). 2001, Vol 6, Num 2, pp 143-144, issn 1359-6535Conference Paper

Marked differences in quantity of infectious human immunodeficiency virus type 1 detected in persons with controlled plasma viremia by a simple enhanced culture methodTREMBLAY, Cécile L; GIGUEL, Francoise; MERRILL, Debra P et al.Journal of clinical microbiology (Print). 2000, Vol 38, Num 11, pp 4246-4248, issn 0095-1137Article

Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100TREMBLAY, Cécile L; KOLLMANN, Christopher; GIGUEL, Francoise et al.Journal of acquired immune deficiency syndromes (1999). 2000, Vol 25, Num 2, pp 99-102, issn 1525-4135Article

Monitoring HIV treatment in developing countriesKOENIG, Serena P; KURITZKES, Daniel R; HIRSCH, Martin S et al.BMJ. British medical journal (International ed.). 2006, Vol 332, Num 7541, pp 602-604, issn 0959-8146, 3 p.Article

TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitroTREMBLAY, Cécile L; GIGUEL, Francoise; YONGBIAO GUAN et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 8, pp 3483-3485, issn 0066-4804, 3 p.Article

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA panelHIRSCH, Martin S; BRUN-VEZINET, Francoise; MELLORS, John W et al.Clinical infectious diseases. 2003, Vol 37, Num 1, pp 113-128, issn 1058-4838, 16 p.Article

Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infectionTREMBLAY, Cecile L; HICKS, Jennifer L; D'AQUILA, Richard T et al.AIDS (London). 2003, Vol 17, Num 7, pp 1086-1089, issn 0269-9370, 4 p.Article

Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infectionSHAFER, Robert W; SMEATON, Laura M; GRIPSHOVER, Barbara M et al.The New England journal of medicine. 2003, Vol 349, Num 24, pp 2304-2315, issn 0028-4793, 12 p.Article

Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS Society-USA panelYENI, Patrick G; HAMMER, Scott M; MONTANER, Julio S. G et al.JAMA, the journal of the American Medical Association. 2002, Vol 288, Num 2, pp 222-235, issn 0098-7484Article

Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppressionHAVLIR, Diane V; GILBERT, Peter B; HOLOHAN, M. K et al.AIDS (London). 2001, Vol 15, Num 11, pp 1379-1388, issn 0269-9370Article

The Future of HIV TreatmentHIRSCH, Martin S; KURITZKES, Daniel R.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, issn 1525-4135, S39-S40, SUP2Conference Paper